vandetanib-eluting radiopaque embolic beads

vandetanib-eluting radiopaque embolic beads · Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for vandetanib-eluting radiopaque embolic beads, covering 2021-02-03 to 2021-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies [EARLY_Phase 1]